Dr Reddys Laboratories Stock Analysis

RDY Stock Analysis Notes

About 15.0% of the company shares are owned by institutional investors. The book value of Dr Reddys was at this time reported as 381.36. The company last dividend was issued on the 30th of July 2024. Dr Reddys Laboratories had 5:1 split on the 5th of November 2024. Reddys Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. Reddys Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India. Dr Reddys operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on New York Stock Exchange. It employs 24795 people. To find out more about Dr Reddys Laboratories contact MARC KIKUCHI at 91 40 4900 2900 or learn more at https://www.drreddys.com.

Dr Reddys Laboratories Investment Alerts

Dr Reddys Laboratories Upcoming and Recent Events

RDY Largest EPS Surprises

View All Earnings Estimates

Dr Reddys Environmental, Social, and Governance (ESG) Scores

Dr Reddys Thematic Classifications

RDY Stock Institutional Investors

Note, although Dr Reddys' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

RDY Market Capitalization

The company currently falls under 'Large-Cap' category with a total capitalization of 11.72 B.

RDY Profitablity

The company has Net Profit Margin of 0.17 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.22 %, which entails that for every 100 dollars of revenue, it generated $0.22 of operating income.

Management Efficiency

Dr Reddys Laboratories has Return on Asset of 0.1032 % which means that on every $100 spent on assets, it made $0.1032 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1847 %, implying that it generated $0.1847 on every 100 dollars invested. Dr Reddys' management efficiency ratios could be used to measure how well Dr Reddys manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.11 in 2025. Return On Capital Employed is likely to drop to 0.11 in 2025. At this time, Dr Reddys' Total Assets are fairly stable compared to the past year. Other Assets is likely to rise to about 8.6 B in 2025, whereas Intangible Assets are likely to drop slightly above 24.7 B in 2025.

Technical Drivers

As of the 25th of March, Dr Reddys owns the Market Risk Adjusted Performance of (0.41), information ratio of (0.04), and Standard Deviation of 1.6. In respect to fundamental indicators, the technical analysis model provides you with a way to check possible technical drivers of Dr Reddys Laboratories, as well as the relationship between them.

Dr Reddys Laboratories Price Movement Analysis

Dr Reddys Outstanding Bonds

Dr Reddys Predictive Daily Indicators

Dr Reddys Corporate Filings

Dr Reddys Forecast Models

Dr Reddys' time-series forecasting models are one of many Dr Reddys' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Dr Reddys' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Dr Reddys prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling RDY shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Dr Reddys. By using and applying RDY Stock analysis, traders can create a robust methodology for identifying RDY entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. RDY analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. RDY analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Dr Reddys Laboratories stock analysis indicators help investors evaluate how Dr Reddys stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Dr Reddys shares will generate the highest return on investment. By understating and applying Dr Reddys stock analysis, traders can identify Dr Reddys position entry and exit signals to maximize returns.

When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.